-
TikTok in the US goes American, but questions remain
-
France probes deaths of two babies after powdered milk recall
-
Across the globe, views vary about Trump's world vision
-
UN rights council decries 'unprecedented' crackdown in Iran, deepens scrutiny
-
Suryakumar, Kishan star as India thrash New Zealand in second T20
-
Spanish prosecutors dismiss sex abuse case against Julio Iglesias
-
Suspected Russia 'shadow fleet' tanker bound for French port
-
UK PM slams Trump for saying NATO troops avoided Afghan front line
-
Arteta tells Nwaneri to 'swim with sharks' on Marseille loan move
-
Snow and ice storm set to sweep US
-
Palmer 'happy' at Chelsea despite homesick speculation: Rosenior
-
Ukraine-Russia-US talks open in Abu Dhabi as Moscow demands Donbas region
-
Ferrari unveil 2026 car with Hamilton ready for 'massive challenge'
-
Welsh full-back Williams retires from international rugby
-
Gold nears $5,000, global stocks muted ending turbulent week
-
Ex-Canadian Olympian turned drug lord arrested: US media
-
A look back at Ukraine war talks
-
France trolls US, Russia misinformation on X
-
Carrick keen for Man Utd to build around 'quality' Mainoo
-
Danish PM visits Greenland for talks after Trump climbdown
-
Reed seizes halfway lead at Dubai Desert Classic
-
Europeans among 150 IS detainees transferred from Syria to Iraq
-
UN expert urges world to reject Myanmar 'sham' election
-
Sarajevo reels under 'extreme' pollution, alert issued
-
Williams to miss opening F1 test due to car delays
-
Ski chief confident of Olympic preparations
-
Man City chasing 'world's best' in Arsenal, says Guardiola
-
Outrage after Trump claims NATO troops avoided Afghan front line
-
German auto supplier ZF axes electric projects as demand stalls
-
ECB chief thanks Davos 'euro-bashers' as welcome wake-up call
-
UK woman felt 'violated, assaulted' by deepfake Grok images
-
France PM survives no-confidence vote over forced budget
-
McCall to step down after 15 years as director of rugby at Saracens
-
Volatile security blocks UN from Syria IS-linked camp
-
Odermatt retains Kitzbuehel super-G in Olympic broadside
-
Did Trump make Davos great again?
-
Fisilau among new faces in England Six Nations squad
-
Long-awaited first snowfall brings relief to water-scarce Kabul
-
Danish, Greenland PMs to meet after Trump climbdown
-
Gold nears $5,000, stocks muted after turbulent week
-
Liverpool on the up as new signings hit form, says Slot
-
Stars turn out for Valentino's funeral in Rome
-
Israeli Bedouin say hope for better life crushed after deadly crackdown
-
Russia demands Ukraine's Donbas region ahead of Abu Dhabi talks
-
Iran lambasts Zelensky after Davos 'bully' warning
-
Gauff hopes to copy 'insane' Osaka fashion statement, but not yet
-
Australian Open to start earlier Saturday over forecast 40C heat
-
Vietnam's To Lam 'unanimously' re-elected party chief
-
Teenager Jovic dumps seventh seed Paolini out of Australian Open
-
'He must hate me': Medvedev renews Tien rivalry at Australian Open
Ozempic Meals? Restaurants shrink portions to match bite-sized hunger
A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.
Then she started Ozempic.
She lost her appetite -- "my desire for cocktails and desserts and anything sweet" -- and also more than 20 pounds (9.1 kilograms) in less than two months.
But "I still wanted to maintain my social lifestyle, and I still wanted to be included in dinners," the Swedish 41-year-old who works in the tequila industry told AFP.
One of her favorite restaurants, Manhattan's Le Petit Village, made that easier: it's among the dining establishments in the city offering smaller portions at lower prices, as the prevalence of medications that reduce hunger like Ozempic grows.
The West Village restaurant decided to shrink a corner of its brunch menu, including French toast and a smoked salmon tartine, not least to accommodate diners on GLP-1s who want to go out but can't eat much.
Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are increasingly popular for weight loss, according to a November poll by the non-profit health policy tracker KFF.
And one in five say they've taken the medications whose brand names include Ozempic and Wegovy -- which are also prescribed to manage chronic conditions like diabetes -- at some point.
On Monday, Danish pharmaceutical giant Novo Nordisk announced US authorities had approved Wegovy to be administered in pill form for weight loss, potentially making it even more accessible.
Some in the restaurant industry are taking note.
"I was going out and seeing people eat a lot less and take one bite of their food and one sip of their drink and that was it," said Aristotle Hatzigeorgiou, who owns Clinton Hall, which has five locations across New York.
And on top of that, much of the dishes his kitchens prepared ended up in the trash -- "a mass amount of waste," he said.
So he developed the "teeny-weeny mini meal" -- for $8, diners get a bite-sized burger, a small portion of fries and their choice of a 3-oz beer, martini or glass of wine.
It's a stark contrast to some of the beer hall's other offerings, which include a "doughnut grilled cheese" and a "fondue burger" (they are what they sound like.)
But the mini-meal has proven a hit, Hatzigeorgiou said, not only for those dropping weight but for those cutting costs.
"I think people are definitely strapped with rents going up and inflation," said the restaurant owner.
Offering "a cheaper option to come out," he said, has "been working."
- 'Vast human experiment' -
For now, GLP-1s for weight loss purposes remain too expensive for many Americans.
But experts expect that will shift; even US President Donald Trump has promised affordable options.
And researchers are starting to examine how wider GLP-1 use is shaking cultural connections to food.
"Food is your enemy, instead of your great pleasure in life? I mean, that's very different," Marion Nestle, a professor emerita of nutrition at New York University, told AFP in an interview. "I think the jury is out on all of it."
Side effects of GLP-1s can include unpleasant gastrointestinal issues, but for some people, Nestle said, the medications have proven "miraculous."
The nutritionist said it's far too soon to have a grasp on long-term impact, physiologically or socioculturally: "It's a vast human experiment."
Axmacher told AFP she's taken Ozempic on and off.
When she first decided to take a break, "I was ready to feel like I could enjoy life a little bit more again."
"I do enjoy the sense of hunger and satisfaction when I get to eat something I'm in the mood for," she said, adding that on Ozempic, "I missed that."
But using the medication also helped her develop positive and sustainable habits, she said: Axmacher cut down on alcohol, exercised more, and focused on eating enough protein.
Ozempic or not, a trend of smaller restaurant dishes in the wake of America's 1990s-2000s Super Size Era can only be positive, Nestle said.
Le Petit Village management told AFP they're considering expanding their menu of half-sized portions to dinner service, and Clinton Hall is working on developing a mini-meal featuring chicken.
Some customers, Hatzigeorgiou said, have noted that "this is what meals used to look like."
"We think it's something different, but maybe it's not so different," he said with a chuckle. "Maybe it's the right-sized meal."
D.Schaer--VB